MedPath

The Impact of Indocyanine Green-enhanced Fluorescence Imaging on Bowel Transection in Left-sided Colorectal Resection

Not Applicable
Conditions
Anastomotic Leak
Interventions
Device: Fluorescence imaging
Registration Number
NCT02669485
Lead Sponsor
The University of Hong Kong
Brief Summary

The aim of this study was to evaluate the impact of fluorescence imaging on the location of colorectal transection lines based on evaluation of perfusion with indocyanine green, how it's going to affect surgical planning and its possible benefits in reducing anastomotic leakage.

Detailed Description

During surgery, the line of intended bowel transection would be determined by the surgeon. Then the anesthesiologist will administer a bolus of 5mg ICG intravenously (2.5mg/ml, 2ml), followed by 10ml normal saline flush. The perfusion of colon will be assessed via fluorescence angiography. The actual bowel transection, after ICG fluorescence study, would be compared with the intended bowel transection site. The difference in terms of distance and either more proximal or distal is recorded. Then bowel anastomosis is completed in the usual manner.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • All left-sided colorectal resection involving division of inferior mesenteric artery
Exclusion Criteria
  • Patients with a history of adverse reaction or known allergy to ICG, iodine, or iodine dyes. Pregnant and/or lactating patients.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
ICGFluorescence imagingAdministering indocyanine green during surgery and the use of ICG fluorescence imaging to assess bowel perfusion during surgery
ICGindocyanine greenAdministering indocyanine green during surgery and the use of ICG fluorescence imaging to assess bowel perfusion during surgery
Primary Outcome Measures
NameTimeMethod
Number of patients with operative decisions changed after the use of ICG enhanced fluorescence imagingintraoperative
Secondary Outcome Measures
NameTimeMethod
Anastomotic leakup to 2 weeks after operation

Trial Locations

Locations (1)

Queen Mary Hospital

🇭🇰

Hong Kong, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath